Joseph Jellicorse, MD
Family Medicine · Carrollton, GANPI 1932190535
Payments from drug & device makers
Across 369 payments — averaging $15.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$795
- Novo Nordisk$658
- AbbVie$607
- Boehringer Ingelheim$586
- Amgen$507
- GSK$418
- plus $2K from 25 others
What the payments were for
- Food & beverage$5,693100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 51 | $795 |
| Novo Nordisk | 44 | $658 |
| AbbVie(2 entities) | 51 | $607 |
| Boehringer Ingelheim | 26 | $586 |
| Amgen | 33 | $507 |
| GSK | 27 | $418 |
| Astellas Pharma US Inc | 21 | $404 |
| AstraZeneca | 28 | $391 |
| Novartis | 22 | $275 |
| Lilly USA, LLC | 13 | $202 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $144 |
| Johnson & Johnson | 8 | $106 |
| Sumitomo Pharma America, Inc. | 6 | $81 |
| Sanofi-aventis U.S. LLC | 4 | $73 |
| Shire North American Group Inc | 4 | $65 |
| Dexcom, Inc. | 3 | $53 |
| Mylan Specialty L.p. | 2 | $34 |
| Jazz Pharmaceuticals Inc. | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Harmony Biosciences LLC | 1 | $27 |
| Genentech USA, Inc. | 1 | $24 |
| Circassia Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Ironwood Pharmaceuticals, Inc | 1 | $17 |
| Shield Therapeutics Inc | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Esperion Therapeutics, Inc. | 1 | $11 |
How this compares
$5,693 in reported general payments places this provider in the 85th percentile of 3,111 family medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 129 | $138,426 |
| JardianceEmpagliflozin | 104 | $118,296 |
| OzempicSemaglutide | 70 | $79,567 |
| MounjaroTirzepatide | 56 | $67,652 |
| MyrbetriqMirabegron | 57 | $49,851 |
| XareltoRivaroxaban | 43 | $42,959 |
| FarxigaDapagliflozin Propanediol | 32 | $37,808 |
| LinzessLinaclotide | 45 | $31,935 |
| GemtesaVibegron | 26 | $31,887 |
| RybelsusSemaglutide | 19 | $29,815 |
| ProliaDenosumab | 16 | $27,584 |
| JanuviaSitagliptin Phosphate | 36 | $27,129 |
| TradjentaLinagliptin | 19 | $23,847 |
| Diclofenac Sodium | 74 | $21,584 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 11 | $18,747 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $586 | $142,142123 claims |
| PfizerEliquis | $795 | $138,426129 claims |
| Novo NordiskOzempic, Rybelsus | $658 | $109,38289 claims |
| Lilly USA, LLCMounjaro, Trulicity | $202 | $83,53067 claims |
| Astellas Pharma US IncMyrbetriq | $404 | $49,85157 claims |
| AstraZenecaFarxiga, Symbicort | $391 | $43,64051 claims |
| Johnson & JohnsonXarelto | $106 | $42,95943 claims |
| AbbVieLinzess, Synthroid | $607 | $37,804125 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $81 | $31,88726 claims |
| AmgenProlia | $507 | $27,58416 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Carrollton
- Joseph SurberColumbus$16.6M
- Angela RitterGainesville$15.8M
- Jeffrey KingsleyColumbus$8.1M
- Christopher OldfieldSavannah$6.4M
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Debbie HaginsSavannah$2.1M
- Aziz PiraniLilburn$2.1M
- Nadia CameronAtlanta$2.1M
- John LentzSnellville$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.